EP1582598A1 - Système optoélectronique rapid pour tests de diagnostic rapide - Google Patents
Système optoélectronique rapid pour tests de diagnostic rapide Download PDFInfo
- Publication number
- EP1582598A1 EP1582598A1 EP04030193A EP04030193A EP1582598A1 EP 1582598 A1 EP1582598 A1 EP 1582598A1 EP 04030193 A EP04030193 A EP 04030193A EP 04030193 A EP04030193 A EP 04030193A EP 1582598 A1 EP1582598 A1 EP 1582598A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- test
- light
- photodetector
- module
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012124 rapid diagnostic test Methods 0.000 title claims abstract description 11
- 230000005693 optoelectronics Effects 0.000 title description 12
- 238000012360 testing method Methods 0.000 claims abstract description 189
- 239000002096 quantum dot Substances 0.000 claims abstract description 33
- 239000000126 substance Substances 0.000 claims abstract description 32
- 239000012491 analyte Substances 0.000 claims abstract description 31
- 238000002372 labelling Methods 0.000 claims abstract description 26
- 230000003287 optical effect Effects 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000008569 process Effects 0.000 claims abstract description 13
- 230000002085 persistent effect Effects 0.000 claims abstract description 10
- 238000003384 imaging method Methods 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 4
- 238000002405 diagnostic procedure Methods 0.000 claims description 4
- 238000005259 measurement Methods 0.000 abstract description 12
- 238000000159 protein binding assay Methods 0.000 abstract description 5
- 238000012545 processing Methods 0.000 abstract description 4
- 239000007850 fluorescent dye Substances 0.000 abstract 1
- 238000001215 fluorescent labelling Methods 0.000 abstract 1
- 230000000007 visual effect Effects 0.000 abstract 1
- 239000000975 dye Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 239000010409 thin film Substances 0.000 description 5
- 230000027455 binding Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000004054 semiconductor nanocrystal Substances 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 229940043517 specific immunoglobulins Drugs 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
Definitions
- Rapid diagnostic test kits are currently available for testing for a wide variety of medical and environmental conditions.
- test kits employ an analyte-specific binding assay to detect or measure a specific environmentally or biologically relevant compound such as a hormone, a metabolite, a toxin, or a pathogen-derived antigen.
- Test strip 100 includes several "zones” that are arranged along a flow path of a sample.
- test strip 100 includes a sample receiving zone 110, a labeling zone 120, a capture or detection zone 130, and an absorbent zone or sink 140.
- Zones 110, 120, 130, and 140, which can be attached to a common backing 150, are generally made of a material such as chemically treated nitrocellulose that allows fluid flow by capillary action.
- test strip 100 and of a lateral flow immunoassay generally is the ease of the testing procedure and the rapid availability of test results.
- a user simply applies a fluid sample such as blood, urine, or saliva to sample receiving zone 110.
- Capillary action then draws the liquid sample downstream into labeling zone 120, which contains a substance for indirect labeling of a target analyte.
- the labeling substances are generally immunoglobulin with attached dye molecules but alternatively may be a non-immunoglobulin labeled compound that specifically binds the target analyte.
- the sample flows from labeling zone 120 into capture zone 130 where the sample contacts a test region or stripe 132 containing an immobilized compound capable of specifically binding the labeled target analyte or a complex that the analyte and labeling substance form.
- analyte-specific immunoglobulins can be immobilized in capture zone 130. Labeled target analytes bind the immobilized immunoglobulins, so that test stripe 132 retains the labeled analytes.
- the presence of the labeled analyte in the sample generally results in a visually detectable coloring in test stripe 132 that appears within minutes of starting the test.
- a control stripe 134 in capture zone 130 is useful for indicating that a procedure has been performed.
- Control stripe 134 is downstream of test stripe 132 and operates to bind and retain the labeling substance. Visible coloring of control stripe 134 indicates the presence of the labeling substance resulting from the liquid sample flowing through capture zone 130.
- test stripe 132 shows no visible coloring, but the accumulation of the label in control stripe 134 indicates that the sample has flown through capture zone 130.
- Absorbent zone 140 then captures any excess sample.
- a quantitative measurement may require determining the number of complexes bound in test stripe 132. Measuring equipment for such determinations can be expensive and is vulnerable to contamination since capture zone 120, which contains the sample, is generally exposed for measurement. Further, the intensity of dyes used in the test typically degrade very rapidly (e.g., within minutes or hours) when exposed to light, so that quantitative measurements based on the intensity of color must somehow account for dye degradation. On the other hand, a home user of a single-use rapid diagnostic test kit may have difficulty interpreting a test result from the color or shade of test stripe 132, particularly since dye intensity within minutes.
- test solution generally contains a labeled compound that specifically binds a target analyte associated with the test being performed.
- the tests are separate because the labeled compounds that bind different target analytes are typically difficult to distinguish if combined in the same solution.
- U.S. Pat. No. 6,630,307 entitled “Method of Detecting an Analyte in a Sample Using Semiconductor Nanocrystals as a Detectable Label,” describes a process that labels binding compounds for different target analytes with different types of semiconductor nanocrystals or quantum dots.
- the different types of nanocrystals when exposed to a suitable wavelength of light fluoresce to produce light of different wavelengths. Accordingly, binding compounds labeled with different combinations of quantum dots can be distinguished by spectral analysis of the fluorescent light emitted from the quantum dots.
- an optoelectronic rapid diagnostic test system can include a light source such as a light emitting diode (LED) or a laser diode that illuminates a test structure such as a test strip.
- the test structure preferably uses a persistent fluorescent substance such as a semiconductor nanocrystal or a quantum dot in a labeling substance for a target analyte.
- the fluorescent substance when bound to the target analyte can be immobilized at a test stripe or region and exposed to light from the light source.
- the persistent fluorescent substance then fluoresces to emit light of a characteristic wavelength.
- An electronic photodetector or an imaging device can then detect the light emitted from the test stripe at the characteristic wavelength and generate an electric signal indicating a test result.
- the test results can be readily quantified since the intensity of the emitted light does not have the rapid time dependence of dyes that are conventionally employed in rapid test systems.
- the optoelectronic portion of the diagnostic test kit can be inexpensively manufactured for disposable or single-use applications.
- the electronic nature of the result signal also lends itself to processing and transmission using many electronic systems.
- control logic in a single-use test module can activate a results indicator (e.g., an external LED or alphanumeric LCD) to unambiguously indicate the test result.
- a single-use test module can include an interface for connection to reusable data processing equipment. The electronic interface avoids the need for reusable equipment to directly measure or be exposed to materials containing the target analyte and thereby reduces the chance for cross contamination during a sequence of tests.
- One specific embodiment of the invention is a rapid diagnostic test system including a photodetector and a light source.
- the light source illuminates a medium containing a sample
- the photodetector measures light from a test area of the medium when the medium is illuminated.
- the medium can be a lateral-flow strip for performing a binding assay and includes a labeling substance that binds a fluorescent structure such as a semiconductor nanocrystal or a quantum dot to a target analyte.
- the photodetector measures light having a frequency characteristic of fluorescent light resulting from illuminating the fluorescent structure.
- the rapid diagnostic test system can further include a second photodetector, and an optical system positioned to receive light from the test area and direct light to the two photodetectors.
- the optical system which can be implemented using diffractive elements or thin-film color filters, filters or directs different colors of light for separate measurement.
- the optical system can separate the light having a first frequency from light having a second frequency, direct the light have the first frequency for measurement by the first photodetector, and direct the light have the second frequency for measurement by the second photodetector.
- the medium can include a first labeling substance that binds a first fluorescent structure to a first target analyte and a second labeling substance that binds a second fluorescent structure to a second target analyte.
- the first fluorescent structure When illuminated, the first fluorescent structure emits light having the first frequency, which the first photodetector measures; and the second fluorescent structure emits light having the second frequency, which the second photodetector measures.
- the photodetector(s) and the medium can be contained in a single-use module that is either a stand-alone device or that requires connection to a reusable module to complete a test.
- the reusable module may have a receptacle into which the single-use module is inserted for communication of electrical and/or optical signals.
- the test process generally includes: applying a sample to a medium in a single-use module that includes a photodetector; illuminating at least a portion of the medium; and generating an electrical test result signal from the photodetector.
- the electrical test result signal can be used in a variety of ways to indicate the test result to a user.
- one variation of the process includes activating a display such as an alphanumeric display or an LED on the single-use module in response to the electrical test result signal.
- An alternative variation of the process includes outputting the electrical test signal from the single-use module to a reusable module. The reusable module can then implement a user interface that informs a user of the test result.
- Fig. 1 shows a conventional test strip for an analyte-specific binding assay.
- Figs. 2A, 2B, 2C, and 2D show cross-sectional views of optoelectronic rapid diagnostic test kits in accordance with alternative embodiments of the invention.
- Fig. 3 illustrates a test system in accordance with an embodiment of the invention using a diffractive optical substrate for focusing and filtering.
- Fig. 4 illustrates a test system in accordance with an embodiment of the invention using refractive lenses and thin-film color filters for optical signals.
- Fig. 5 is a cutaway view of a test system in accordance with an embodiment of the invention containing a battery with a pull-tab for test activation.
- Fig. 6 is a perspective view of a test system in which the sample receiving zone of a test strip is inside a case and accessible through an opening in the case.
- Figs. 7A and 7B are perspective views of test systems in accordance with embodiments of the invention in which single-use optoelectronic devices have electrical interfaces for communication with reusable test stations.
- a rapid diagnostic test system employs a disposable optoelectronic device that generates an electronic test result signal.
- the optoelectronic device preferably contains or is used with a test strip or test structure using a labeling substance that binds a persistent fluorescent substance such as a quantum dot to the target analyte.
- the test system can include a light source that illuminates a test area with light of the proper wavelength to cause fluorescence and a photodetector such as a photodiode that measures the resulting fluorescent light to detect the target analyte.
- Fig. 2A shows a cross-section of a test system 200 in accordance with an embodiment of the invention where an optoelectronic device reads a test result.
- system 200 can test for any desired medical or environmental condition or substance including but not limited to glucose, pregnancy, infectious diseases, cholesterol, cardiac markers, signs of drug abuse, chemical contaminants, or biotoxins.
- System 200 includes a case 210, a test strip 220, and a circuit 240 including a light source 250, a battery 252, a control unit 254, and photodetectors 256 and 258.
- Case 210 can be made of plastic or other material suitable for safely containing the liquid sample being analyzed.
- case 210 has an opening through which a portion of test strip 220 extends for application of the sample to a sample receiving zone 222 of test strip 220.
- test strip 220 can be enclosed in case 210, and application of the sample to test strip 220 is through an opening in case 210.
- Test strip 220 can be substantially identical to a conventional test strip such as test strip 100 described above in regard to Fig. 1, but in test strip 220, the substance for labeling the target analyte preferably includes a quantum dot or a similar structure that fluoresces at a constant intensity when exposed to light of the proper wavelength.
- the substance for labeling the target analyte preferably includes a quantum dot or a similar structure that fluoresces at a constant intensity when exposed to light of the proper wavelength.
- a user applies a sample to sample receiving zone 222 of test strip 220.
- the sample flows from receiving zone 222 into a labeling zone 224 inside case 210.
- the labeling substance binds the quantum dot or other persistent fluorescent structure to the target analyte.
- the sample including the labeling substance then enters a capture or detection zone that includes a test stripe 226 and a control stripe 228.
- Test stripe 226 is a region containing an immobilized substance selected to bind and retain the labeled complex containing the target analyte and the quantum dot.
- Control stripe 228 is a region containing an immobilized substance selected to bind to and retain to the labeling substance.
- Light source 250 in circuit 240 illuminates test stripe 226 and control stripe 228 during testing.
- Light source 250 is preferably a light emitting diode (LED) or a laser diode that emits light of a frequency that causes fluorescence of any quantum dots in test stripe 226 or control stripe 228.
- the quantum dots fluoresce under a high frequency (or short wavelength) light, e.g., blue to ultraviolet light, and the fluorescent light has a lower frequency (or a longer wavelength) than the light from light source 250.
- Photodetectors 256 and 258 are in the respective paths of light emitted from test stripe 226 and control stripe 228 and measure the fluorescent light from the respective stripes 226 and 228.
- a baffle or other light directing structure (not shown) can be used to direct light from test stripe 226 to photodetector 256 and light from control strip 228 to photodetector 258.
- photodetectors 256 and 258 have respective color filters 257 and 259 that transmit light of the frequency associated with the selected fluorescent light but blocks other frequencies, especially the frequency of light emitted from light source 250.
- the labeling substance can include two types of quantum dots.
- One of the types of quantum dots emits a first wavelength of light and is attached to a substance that binds to the target analyte and to test stripe 226.
- the other type of quantum dot emits light of a second wavelength and binds to control stripe 228.
- Color filters 257 and 259 can then be designed so that photodetector 256 measures fluorescent light from the type of quantum dot that test stripe 226 traps when the target analyte is present while photodetector 258 measures fluorescent light from the type of quantum dot that control strip 228 traps.
- Quantum dots provide fluorcscent light at an intensity that is consistent for long periods of time, instead of rapidly degrading in the way that the intensity of conventional test dyes degrade when exposed to light.
- the intensity measurements from detectors 256 and 258, which indicate the amount of fluorescent light are proportional to the number of quantum dots in the respective stripes 226 and 228 and are not subject to rapid changes with time. These intensity measurements thus provide a quantitative indication of the concentration of the target analyte.
- Control unit 254 which can be a standard microcontroller or microprocessor with an analog-to-digital converter, receives electrical signals from detectors 256 and 258.
- the electric signals indicate the measured intensities from stripes 226 and 228, and control unit 254 processes the electrical test signals and then operates an output system as required to indicate test results.
- the output system includes LED lights 261 and 263.
- Control unit 254 can activate one light 261 when the fluorescent light from the test stripe 226 is above a threshold level marking the presence of the target analyte in test stripe 226.
- Control unit 254 can activate the other light 262 when the intensity of fluorescent light from test stripe 226 is below the threshold level but the intensity that photodetector 258 measures from control stripe 228 is above a threshold level therefore indicating that the sample has passed through test stripe 226.
- a system with three or more LEDs or particular patterns of flashing of one or more LEDs can similarly indicate other test results (e.g., an inconclusive test) or a test status (e.g., to indicate a test in progress).
- Fig. 2B illustrates a test system 200B that is similar to test system 200 but includes an alphanumeric display 264 for output of test results.
- a two or three character LCD array could provide numeric output based on the measured intensity of fluorescent light from test stripe 226.
- Display 264 may be used in conjunction with LEDs such as illustrated in Fig. 2A or other output systems.
- Fig. 2C illustrates a test system 200C using yet another test result output technique.
- test system 200C outputs an electric signal via external terminals 266 to indicate the test result.
- test system 200C can thus provide the electric test result signal to an electronic device (not shown) that can process, convert, or transmit the test result signal.
- An advantage of test system 200C is that circuit components such as battery 252 can be removed from circuit 240 to reduce the cost of test system 200C, and power can be supplied to circuit 240 through external terminals 266.
- Fig. 2D illustrates a test system 200D in accordance with an embodiment of the invention that employs an imaging system 255 for detection of fluorescent light.
- Imaging system 255 can include a two-dimensional CCD or CMOS imaging array or similar optoelectronic imager capable of generating an electronic representation of an image (e.g., an array of pixel values representing a captured image or frame).
- Control unit 254 can analyze digital images from imaging system 255 to determine the intensity and color of light emitted from stripes 226 and 228. Test results can then be output based on the analysis of the image.
- test systems 200, 200B, 200C, and 200D include the ease with which a user receives the test result and the consistency and accuracy of the test results.
- LED lights 261 and 262 and alphanumeric displays provide results that a user can easily read.
- a conventional rapid diagnostic test relying on a dye to indicate a test result may require that a user distinguish a shade or intensity in a test stripe. This interpretation may be subject to user judgment errors and to dyes that fade within minutes after exposure to light.
- the fluorescence from quantum dots does not fade rapidly with time, and circuit 240 produces a non-subjective and/or quantitative interpretation of the intensity of the fluorescent light.
- FIG. 3 shows a portion of a test system 300 in accordance with an embodiment of the invention that tests for the presence of multiple target analytes in a sample.
- Test system 300 includes a test strip 320, an optoelectronic circuit 340, and an intervening optical system 330.
- Test strip 320 can be substantially identical to test strip 220, which is described above, but test strip 320 includes multiple labeling substances corresponding to different target analytes. Each labeling substance binds a corresponding type of quantum dot to a corresponding target analyte.
- the quantum dots for different labeling substances preferably produce fluorescent light having different characteristic wavelengths (e.g., 525, 595, and 655 nm). Suitable quantum dots having different fluorescent frequencies and biological coatings suitable for binding to analyte-specific immunoglobulins are commercially available from Quantum Dot, Inc.
- Test strip 320 includes a test stripe 326 that is treated to bind to and immobilize the different complexes including the target analytes and respective labeling substances. Testing for multiple analytes in the same test structure is particularly desirable for cholesterol or cardiac panel test system that measures multiple factors.
- Light source 250 illuminates test stripe 326 with light of a wavelength that causes all of the different quantum dots to fluoresce. Fluorescent light from test strip 326 will thus contain fluorescent light of different wavelengths if more than one of the target analytes are present in test strip 326.
- Optical system 330 separates the different wavelengths of light and focuses each of the different wavelengths on a corresponding photodetector 342, 343, or 344.
- Photodetectors 342, 343, and 344 which can further include appropriate color filters, thus provide separate electrical signals indicating the number of quantum dots of the respective types in test stripe 326 and therefore indicate concentrations of the respective target analytes. Control and output circuits (not shown) can then provide the test results to a user or a separate device as described above in regards to Figs. 2A, 2B, and 2C.
- Optical system 330 in Fig. 3 is an optical substrate providing diffractive focusing of the different wavelengths on different photodetectors 342, 343, and 344.
- optical system 330 includes an optical substrate of a material such as glass or plastic with opaque regions or surface discontinuities in a pattern that provides a desired separation or focusing of the different fluorescent wavelengths.
- diffractive optical elements such as optical system 330 can be fabricated inexpensively using other processes and structures.
- Fig. 4 shows a portion of test system 400 that is similar to test system 300 of Fig. 3, but test system 400 includes an optical system 430 formed from refractive lenses 431, 432, 433, and 434 and thin-film color filters 436, 437, and 438 on prisms.
- lens 431 receives and collimates fluorescent light emitted from test stripe 326 when light source 250 illuminates quantum dots in test stripe 326.
- Color filter 436 is designed to transmit light of a frequency corresponding to the quantum dots that photodetector 342 measures and to reflect light of the frequency emitted by light source 250 or resulting from fluorescence of other types of quantum dots.
- Thin films that transmit light of the desired wavelength but reflect light of the other wavelengths can be designed and constructed from a stack of dielectric layers having thicknesses and refractive indices that achieve the desired characteristics.
- color filter 436 could include a diffractive index grating filter or a colored material.
- Lens 432 focuses the light transmitted through filter 436 onto the photosensitive area of detector 342, which can include a further color filter for additional selectivity to the desired color of light.
- Filter 437 is designed to reflect light of the wavelength corresponding to detector 343 and transmit the unwanted wavelengths.
- Lens 433 focuses the light reflected from filter 437 onto the photosensitive area of detector 343.
- Light transmitted through filter 437 is incident of filter 438, which is designed to reflect light of the wavelength corresponding to detector 344 and transmit the unwanted wavelengths.
- Lens 434 focuses the light reflected from filter film 438 onto the photosensitive area of detector 344.
- Optical systems 330 and 430 merely provide illustrative examples of an optical system using diffractive elements or thin-film filters for separating different wavelengths of light for measurements.
- Optical systems using other techniques e.g., a chromatic prism
- the characteristics and geometry of such optical systems will generally depend on the number of different types of quantum dots used and the wavelengths of the fluorescent light.
- Fig. 5 illustrates a cutaway view of a test system 500 in accordance with an embodiment of the invention.
- test system 500 includes a case 510 having a first slot at one end through which a test strip 520 extends and second slot at the opposite end through which a pull tab 530 extends.
- An optoelectronic circuit 540 including a light source 250, batteries 252, and other desired circuit elements is enclosed inside case 510.
- An optical system (not shown) may additionally be included in case 510 for separation of optical signals or for focusing light onto one or more photodetectors in circuit 540.
- Test strip 520 can be substantially identical to test strip 220 or 320, which are described above for measuring one or more target analytes.
- Pull tab 530 acts as a switch and is initially between a battery 252 and a contact that connects battery 252 to provide power to circuit 540.
- a user applies a sample to the exposed portion of test strip 520 and pulls tab 530 out of case 510 to activate circuit 540.
- Circuit 540 then illuminates test strip 520, measures the intensity of the resulting fluorescence from a target area of test strip 520, and generates an output signal.
- Fig. 6 illustrates a test system 600 in accordance with an embodiment of the invention that encloses a test strip 520 inside a case 610.
- case 610 includes an opening 612 that funnels the sample onto a sample receiving zone of test strip 520.
- An advantage of case 610 is an improved isolation of test strip 520 after introduction of the sample.
- a cap (not shown) can then be used to cover opening 612 to further improve isolation of the sample during handling of test system 600 after introduction of the sample.
- Fig. 6 also illustrates that test system 600 can include a pull tab 530 for beginning the electrical operation of test kit 600 and external LEDs 614 and 614 for indication of test status and results.
- Fig. 7A illustrates a test system 700 in accordance with yet another embodiment of the invention.
- Test system 700 includes a single-use module 710 and a reusable module 720.
- Single-use module 710 includes a test strip 520 that is accessible through an opening 712 in a case 714 in a manner similar to that described above in regard to test system 600 of Fig. 6.
- Single-use module 710 has an electrical interface including terminals 716 that can be plugged into receptacle 722 of reusable module 720.
- Reusable module 720 can then display a test result on an LCD display 724 or any other suitable user interface.
- Modules 710 and 720 collectively form an optoelectronic circuit capable of reading, analyzing, and providing test results.
- single-use module 710 includes one or more photodetectors and optical filters for the fluorescent light generated from test strip 520.
- the light source is generally in single use module 710 but can alternatively be included in reusable module 720 when single-use module 710 has a window or other optical interface that can convey light of the desired frequency into module 710.
- Reusable module 720 can include the other circuit elements such as control circuits, batteries, and user interface electronics such as display 724. Through receptacle 722 and terminals 716, reusable module 720 can thus supply power to single-use module 710 and can receive a test result signal.
- test result signal is the analog electric output signals directly from photodetectors in single-use module 710.
- single-use module 710 can include amplifiers, analog-to-digital converters, and/or other initial signal processing elements that provide a preprocessed signal to reusable module 720.
- test system 700 is reduction in the cost of the disposable or single-use module 710.
- the cost for repeated tests is decreased and the sophistication of the test result output can be increased (e.g., with alphanumeric or audible output instead of warning lights). This is particularly useful for tests that are repeated such as home testing of glucose levels or almost any diagnostic test performed at a doctor's office.
- reusable module 720 receives an electric signal from single-use module 710 and does not need to directly measure test strip 520 containing a sample. Reusable module 720 is thus not subject to sample contamination that might affect the results of subsequent tests.
- Fig. 7B illustrates a test system 750 illustrating using the single-use module 710 with a more elaborate reusable module 730.
- reusable module 730 includes a receptacle 732, a display 734, a keypad 736, and a port 738.
- Receptacle 732 can be substantially identical to receptacle 722 of Fig. 7A and serves to accommodate single-use module 710 for transmission of power and signals between the two modules 730 and 710.
- Display 734 which can be an LCD display, a touch screen, or a similar device, is part of the user interface of reusable module 730 and can display any desired information including test results and control information.
- Keypad 736 provides a user interface for input of data or system control parameters.
- Port 738 provides a connection to other systems such as a computer or communication network and can be, for example, a jack for modem communications via telephone lines, USB or fire wire, or Ethernet standards to name a few.
- a test system employs a relatively simple reusable module 720 as in system 700 of Fig. 7A or a more complex reusable module 730 as shown in Fig. 7B will generally depend on the type of testing performed and the results needed.
- a commercial product might include one reusable module 720 with a set of six or more single-use modules 710 with the intent being that reusable module 720 is used only a limited number of times (e.g., just with the single use modules in the same package).
- reusable module 730 may be intended for use in a large number of tests and sold separately from single-use modules 710.
- single-use modules that perform different tests may be made compatible with a standardized reusable module 730, which would permit use of reusable module 730 in a doctor's office, for example, for control and output of many different types of tests.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Optics & Photonics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Theoretical Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mathematical Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US816636 | 1991-12-31 | ||
US10/816,636 US20050221504A1 (en) | 2004-04-01 | 2004-04-01 | Optoelectronic rapid diagnostic test system |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1582598A1 true EP1582598A1 (fr) | 2005-10-05 |
EP1582598B1 EP1582598B1 (fr) | 2008-01-23 |
Family
ID=34887768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04030193A Active EP1582598B1 (fr) | 2004-04-01 | 2004-12-20 | Système optoélectronique rapid pour tests de diagnostic rapide |
Country Status (5)
Country | Link |
---|---|
US (2) | US20050221504A1 (fr) |
EP (1) | EP1582598B1 (fr) |
CN (1) | CN1677105A (fr) |
CA (1) | CA2496986A1 (fr) |
DE (1) | DE602004011471T2 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008019695A2 (fr) * | 2006-08-16 | 2008-02-21 | Thor Publishing | système d'essai interactif permettant d'analyser des échantillons biologiques |
WO2012010454A1 (fr) * | 2010-07-20 | 2012-01-26 | F. Hoffmann-La Roche Ag | Dispositif de détection d'un analyte dans un liquide corporel |
DE102006003380B4 (de) * | 2005-01-26 | 2013-02-07 | Alverix, Inc. | Untersuchungsteststreifen mit mehreren Markierungen und Lesen derselben |
WO2015024553A1 (fr) * | 2013-08-20 | 2015-02-26 | opTricon Entwicklungsgesellschaft für Optische Technologien mbH | Dispositif de lecture numérique pour des tests de diagnostic rapide |
GB2542802A (en) * | 2015-09-30 | 2017-04-05 | Cambridge Display Tech Ltd | Organic-based fluorescence sensor with low background signal |
US9851366B2 (en) | 2011-01-18 | 2017-12-26 | Symbolics, Llc | Lateral flow assays using two dimensional features |
US9874556B2 (en) | 2012-07-18 | 2018-01-23 | Symbolics, Llc | Lateral flow assays using two dimensional features |
WO2020049066A1 (fr) * | 2018-09-04 | 2020-03-12 | Ams Ag | Lecteur de biomarqueurs |
EP3772646B1 (fr) * | 2019-08-06 | 2024-04-24 | ams-OSRAM AG | Bande de test, dispositif de surveillance et procédé de fabrication d'une bande de test |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
CA2556331A1 (fr) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Procede et systeme de communication de donnees dans un systeme de controle et de gestion de glucose en continu |
US8128871B2 (en) | 2005-04-22 | 2012-03-06 | Alverix, Inc. | Lateral flow assay systems and methods |
US20070185679A1 (en) * | 2004-04-01 | 2007-08-09 | Petruno Patrick T | Indicating status of a diagnostic test system |
US20070143035A1 (en) * | 2005-12-19 | 2007-06-21 | Petruno Patrick T | Diagnostic test reader with disabling unit |
US9891217B2 (en) | 2005-04-22 | 2018-02-13 | Alverix, Inc. | Assay test strips with multiple labels and reading same |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
JP4695025B2 (ja) * | 2006-06-19 | 2011-06-08 | 株式会社日立製作所 | 生体及び化学反応分析キット |
KR20090024731A (ko) * | 2006-06-28 | 2009-03-09 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | 착탈식 모듈을 구비하는 일회용 분석 디바이스 및 원격 데이터 전송 시스템 |
US20080081002A1 (en) * | 2006-09-29 | 2008-04-03 | Patrick Petruno | Diagnostic assay reader having multiple power configurations |
US7532128B2 (en) * | 2006-10-25 | 2009-05-12 | Alverix, Inc. | Position sensitive indicator detection |
EP2104854A1 (fr) * | 2007-01-08 | 2009-09-30 | 3M Innovative Properties Company | Dispositif permettant de déterminer la qualité d'huiles de cuisson et procédés |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
JP2008241686A (ja) * | 2007-02-26 | 2008-10-09 | Fujitsu Ltd | 標的検出装置及び標的検出方法 |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
WO2008130895A2 (fr) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Procédé et appareil pour assurer une amplification de signal dynamique à étapes multiples dans un dispositif médical |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
WO2008157820A1 (fr) | 2007-06-21 | 2008-12-24 | Abbott Diabetes Care, Inc. | Dispositifs et procédés de gestion de la santé |
JP2010531169A (ja) | 2007-06-21 | 2010-09-24 | アボット ダイアベティス ケア インコーポレイテッド | 健康監視装置 |
JP5507475B2 (ja) * | 2008-03-04 | 2014-05-28 | スリーエム イノベイティブ プロパティズ カンパニー | 組み合わされた光学的読み取り呼出し方法及びデバイスを用いたフライ油の品質のモニタリング |
WO2009111372A2 (fr) * | 2008-03-04 | 2009-09-11 | 3M Innovative Properties Company | Procédés et dispositifs pour suivre la qualité d’huile de friture |
CN101514987B (zh) * | 2008-07-14 | 2012-11-21 | 马义才 | 量子点标记试条定量检测系统及其检测方法 |
US20100176279A1 (en) * | 2009-01-14 | 2010-07-15 | Alverix, Inc. | Methods and materials for detecting light released from a labeling material |
KR101605670B1 (ko) * | 2009-01-28 | 2016-03-23 | 스미또모 가가꾸 가부시키가이샤 | 자외선 경화 수지의 상태 추정 방법 및, 그의 제조 방법 |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
CN101592659B (zh) * | 2009-02-09 | 2012-08-08 | 马义才 | 一种基于持续荧光物标记的试条定量检测系统及其方法 |
DE102009010563A1 (de) | 2009-02-16 | 2010-08-26 | Matthias W. Engel | Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
WO2010138856A1 (fr) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Systèmes d'antenne de dispositif médical comportant des configurations d'antenne externe |
WO2011026147A1 (fr) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Dispositif et procédés de traitement de signal d'analyte |
EP3001194B1 (fr) | 2009-08-31 | 2019-04-17 | Abbott Diabetes Care, Inc. | Dispositifs médicaux et procédés |
EP2473099A4 (fr) | 2009-08-31 | 2015-01-14 | Abbott Diabetes Care Inc | Système de surveillance de substance à analyser et procédés de gestion de l'énergie et du bruit |
EP2482720A4 (fr) | 2009-09-29 | 2014-04-23 | Abbott Diabetes Care Inc | Procédé et appareil de fourniture de fonction de notification dans des systèmes de surveillance de substance à analyser |
US9877672B2 (en) | 2010-01-28 | 2018-01-30 | Ellume Pty Ltd | Sampling and testing device for the human or animal body |
US8655009B2 (en) * | 2010-09-15 | 2014-02-18 | Stephen L. Chen | Method and apparatus for performing color-based reaction testing of biological materials |
US8506901B2 (en) | 2010-11-03 | 2013-08-13 | Teco Diagnostics | All-in-one specimen cup with optically readable results |
CN103619255B (zh) | 2011-02-28 | 2016-11-02 | 雅培糖尿病护理公司 | 与分析物监测装置关联的装置、系统和方法以及结合了它们的装置 |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
WO2013066847A1 (fr) * | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Capteur de substance à analyser |
AU2012335830B2 (en) | 2011-11-07 | 2017-05-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
CN102495036A (zh) * | 2011-12-07 | 2012-06-13 | 长春美泰科技有限公司 | 生活用纸制品荧光增白剂现场检测仪 |
US9311520B2 (en) | 2012-08-08 | 2016-04-12 | Scanadu Incorporated | Method and apparatus for performing and quantifying color changes induced by specific concentrations of biological analytes in an automatically calibrated environment |
US9528941B2 (en) | 2012-08-08 | 2016-12-27 | Scanadu Incorporated | Method and apparatus for determining analyte concentration by quantifying and interpreting color information captured in a continuous or periodic manner |
US9285323B2 (en) | 2012-08-08 | 2016-03-15 | Scanadu Incorporated | Quantifying color changes of chemical test pads induced concentrations of biological analytes under different lighting conditions |
US20140072959A1 (en) | 2012-09-12 | 2014-03-13 | Force Diagnostics, Inc. | Rapid tests for insurance underwriting |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US10890590B2 (en) | 2012-09-27 | 2021-01-12 | Ellume Limited | Diagnostic devices and methods |
WO2014134033A1 (fr) | 2013-02-26 | 2014-09-04 | Astute Medical, Inc. | Évaluation d'écoulement latéral avec rétenteur de bande d'essai |
AU2013202805B2 (en) | 2013-03-14 | 2015-07-16 | Gen-Probe Incorporated | System and method for extending the capabilities of a diagnostic analyzer |
TWI468760B (zh) * | 2013-04-01 | 2015-01-11 | Delta Electronics Inc | 光學模組及光收發模組 |
ITVR20130132A1 (it) * | 2013-05-29 | 2014-11-30 | Optoelettronica Italia S R L | Kit per il rilevamento di micro-rna estratto da un campione di fluido corporeo nonché metodo per il rilevamento dello stesso |
JP6382309B2 (ja) * | 2013-07-12 | 2018-08-29 | カルロバッツ,ネベン | トランスビジュアル感度を有する汎用迅速診断検査リーダー |
EP3044592B1 (fr) | 2013-09-13 | 2019-07-17 | Symbolics, LLC | Measures d'écoulement latéral utilisant des motifs d'essai bidimensionnel et de lecture de signal témoin |
GB201321430D0 (en) | 2013-12-04 | 2014-01-15 | Spd Swiss Prec Diagnostics Gmbh | Assay device |
EP2905607A1 (fr) | 2014-02-07 | 2015-08-12 | Nxp B.V. | Procédés et dispositifs de détection d'analyte |
WO2016025935A2 (fr) | 2014-08-15 | 2016-02-18 | Scanadu Incorporated | Procédés de luxmètre de précision pour caméras numériques pour quantifier des couleurs dans des environnements à éclairage non commandé |
EP3248001B1 (fr) | 2015-01-22 | 2019-09-18 | Ellume Pty Ltd. | Dispositifs pour l'établissement de diagnostic et méthodes permettant d'atténuer l'effet crochet et utilisation de ceux-ci |
WO2016164365A1 (fr) | 2015-04-06 | 2016-10-13 | Bludiagnostics, Inc. | Dispositif d'essai pour détection d'une substance à analyser dans un échantillon de salive et procédé d'utilisation |
EP3078975B1 (fr) | 2015-04-10 | 2021-06-09 | Nokia Technologies Oy | Appareil et procédé de détection |
CN104730000A (zh) * | 2015-04-13 | 2015-06-24 | 大连理工大学 | 一种免疫层析反应结果的光电量化检测装置 |
CN105181661A (zh) * | 2015-08-11 | 2015-12-23 | 郑州安图生物工程股份有限公司 | 荧光定量联合检测弓形虫IgG、IgM抗体试剂盒 |
CN105259151B (zh) * | 2015-11-02 | 2018-07-31 | 深圳市锦瑞生物科技有限公司 | 一种荧光检测系统及仪器 |
EP3504551A1 (fr) | 2016-08-23 | 2019-07-03 | Qoolabs, Inc. | Dosage à écoulement latéral pour évaluer l'expression de protéines recombinées ou l'expression de gènes reporters |
AU2017366779B2 (en) * | 2016-11-30 | 2023-06-01 | Idexx Laboratories, Inc. | Lateral flow assay reader based on human perception and method relating thereto |
GB2563581A (en) * | 2017-06-16 | 2018-12-26 | Sumitomo Chemical Co | Device |
CN108982833A (zh) * | 2018-04-17 | 2018-12-11 | 山东安博仪器股份有限公司 | 一种孔雀石绿的检测试纸及检测方法 |
CN109357975B (zh) * | 2018-10-31 | 2021-05-18 | 福州大学 | 一种测量生物分子有效扩散系数的方法 |
WO2021216958A1 (fr) * | 2020-04-24 | 2021-10-28 | The Regents Of The University Of California | Dispositifs et procédés de détection de protéines et de particules à deux dimensions (2d) |
JP2023541663A (ja) | 2020-09-17 | 2023-10-03 | スキャンウェル ヘルス インコーポレイテッド | 診断試験キット及びその分析方法 |
USD970033S1 (en) | 2020-10-23 | 2022-11-15 | Becton, Dickinson And Company | Cartridge imaging background device |
US11988596B2 (en) | 2020-10-23 | 2024-05-21 | Becton, Dickinson And Company | Systems and methods for imaging and image-based analysis of test devices |
DE112021006065T5 (de) * | 2020-11-20 | 2023-09-14 | Ams-Osram Ag | Teststreifenkassette, überwachungsvorrichtung und verfahren zur herstellung einer teststreifenkassette |
CN114413944B (zh) * | 2022-03-29 | 2022-06-21 | 安徽省国盛量子科技有限公司 | 一种基于量子点的分布式光纤传感器 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020146844A1 (en) * | 1995-08-09 | 2002-10-10 | Karen B. Dow Morrison And Foerster Llp | One-step lateral flow assays |
WO2003098278A2 (fr) * | 2002-05-17 | 2003-11-27 | Applera Corporation | Appareil et procede pour differencier par longueur d'onde d'excitation des signaux de fluorescence multiples |
WO2004003527A1 (fr) * | 2002-06-27 | 2004-01-08 | Unipath Limited | Lecteur de test |
US20040018637A1 (en) * | 1998-11-23 | 2004-01-29 | Polito Alan J. | Method and apparatus for performing a lateral flow assay |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US5132097A (en) * | 1987-02-11 | 1992-07-21 | G.D. Research | Apparatus for analysis of specific binding complexes |
US4902278A (en) * | 1987-02-18 | 1990-02-20 | Ivac Corporation | Fluid delivery micropump |
EP0291194B8 (fr) * | 1987-04-27 | 2003-10-22 | Inverness Medical Switzerland GmbH | Dosages immunologiques et appareils pour leur mise en oeuvre |
US5442169A (en) * | 1991-04-26 | 1995-08-15 | Paul Scherrer Institut | Method and apparatus for determining a measuring variable by means of an integrated optical sensor module |
ES2103330T3 (es) * | 1991-10-14 | 1997-09-16 | Mars Inc | Dispositivo para el reconocimiento optico de documentos. |
US5217832A (en) * | 1992-01-23 | 1993-06-08 | The Walt Disney Company | Permanent color transparencies on single substrates and methods for making the same |
US5371687A (en) * | 1992-11-20 | 1994-12-06 | Boehringer Mannheim Corporation | Glucose test data acquisition and management system |
US5837546A (en) * | 1993-08-24 | 1998-11-17 | Metrika, Inc. | Electronic assay device and method |
WO1995006240A1 (fr) * | 1993-08-24 | 1995-03-02 | Metrika Laboratories, Inc. | Nouveau dispositif electronique d'analyse jetable |
US5723294A (en) * | 1996-03-05 | 1998-03-03 | Gull Laboratories | Methods for detection and discrimination of multiple analytes using fluorescent technology |
US5961451A (en) * | 1997-04-07 | 1999-10-05 | Motorola, Inc. | Noninvasive apparatus having a retaining member to retain a removable biosensor |
US6046051A (en) * | 1997-06-27 | 2000-04-04 | Hemosense, Inc. | Method and device for measuring blood coagulation or lysis by viscosity changes |
US6585341B1 (en) * | 1997-06-30 | 2003-07-01 | Hewlett-Packard Company | Back-branding media determination system for inkjet printing |
US6561643B1 (en) * | 1997-06-30 | 2003-05-13 | Hewlett-Packard Co. | Advanced media determination system for inkjet printing |
WO2000006990A2 (fr) * | 1998-07-27 | 2000-02-10 | Ljl Biosystems, Inc. | Appareil et des procedes de mesures spectroscopiques a resolution temporelle |
US6394952B1 (en) * | 1998-02-03 | 2002-05-28 | Adeza Biomedical Corporation | Point of care diagnostic systems |
US20010035990A1 (en) * | 1998-04-13 | 2001-11-01 | Fai H Mok | Multiplexed hologram copying system and method |
JP3969467B2 (ja) * | 1998-06-17 | 2007-09-05 | 富士通株式会社 | ネットワークシステム、送受信方法、送信装置、受信装置、および、記録媒体 |
US6217744B1 (en) * | 1998-12-18 | 2001-04-17 | Peter Crosby | Devices for testing fluid |
AU5646800A (en) * | 1999-03-02 | 2000-09-21 | Helix Biopharma Corporation | Card-based biosensor device |
DE60042738D1 (de) * | 1999-05-07 | 2009-09-24 | Life Technologies Corp | Verfahren zum nachweis von analyten mit hilfe von halbleiternanokrystallen |
US20020004246A1 (en) * | 2000-02-07 | 2002-01-10 | Daniels Robert H. | Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels |
US6671428B1 (en) * | 2000-12-01 | 2003-12-30 | Bayspec, Inc. | Wavelength selective optical cross switch and optical add/drop multiplexer using volume phase grating and array of micro electro mechanical mirrors |
US6572745B2 (en) * | 2001-03-23 | 2003-06-03 | Virotek, L.L.C. | Electrochemical sensor and method thereof |
US20020176927A1 (en) * | 2001-03-29 | 2002-11-28 | Kodas Toivo T. | Combinatorial synthesis of material systems |
US20020143844A1 (en) * | 2001-03-29 | 2002-10-03 | Wen-Sung Tsai | Computer system with two operating systems |
US6379622B1 (en) * | 2001-04-11 | 2002-04-30 | Motorola, Inc. | Sensor incorporating a quantum dot as a reference |
JP2005508495A (ja) * | 2001-09-06 | 2005-03-31 | ジェノミック プロファイリング システムズ インコーポレイティッド | 分子の迅速かつ高感度の検出法 |
US7635588B2 (en) * | 2001-11-29 | 2009-12-22 | Applied Biosystems, Llc | Apparatus and method for differentiating multiple fluorescence signals by excitation wavelength |
US20030119203A1 (en) * | 2001-12-24 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay devices and methods for conducting assays |
US8367013B2 (en) * | 2001-12-24 | 2013-02-05 | Kimberly-Clark Worldwide, Inc. | Reading device, method, and system for conducting lateral flow assays |
US6717967B2 (en) * | 2002-03-18 | 2004-04-06 | Dicos Technologies Inc. | Absolutely calibrated periodic filters and sources |
US20030207454A1 (en) * | 2002-05-01 | 2003-11-06 | Eyster Curt R. | Devices and methods for analyte concentration determination |
US6750963B2 (en) * | 2002-05-21 | 2004-06-15 | Agilent Technologies, Inc. | Imaging systems for signals on a surface |
US6987259B2 (en) * | 2002-05-30 | 2006-01-17 | Dmetrix, Inc. | Imaging system with an integrated source and detector array |
US6875185B2 (en) * | 2002-07-29 | 2005-04-05 | Branan Medical Corporation | Integrated confirmation sample in a body fluid test device and method of using |
US7285424B2 (en) * | 2002-08-27 | 2007-10-23 | Kimberly-Clark Worldwide, Inc. | Membrane-based assay devices |
US7220597B2 (en) * | 2003-01-30 | 2007-05-22 | Zin Benedict L | Assay test device and method of making same |
-
2004
- 2004-04-01 US US10/816,636 patent/US20050221504A1/en not_active Abandoned
- 2004-12-20 DE DE602004011471T patent/DE602004011471T2/de active Active
- 2004-12-20 EP EP04030193A patent/EP1582598B1/fr active Active
-
2005
- 2005-01-26 US US11/044,394 patent/US20050221505A1/en not_active Abandoned
- 2005-02-14 CA CA002496986A patent/CA2496986A1/fr not_active Abandoned
- 2005-04-01 CN CNA2005100598923A patent/CN1677105A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020146844A1 (en) * | 1995-08-09 | 2002-10-10 | Karen B. Dow Morrison And Foerster Llp | One-step lateral flow assays |
US20040018637A1 (en) * | 1998-11-23 | 2004-01-29 | Polito Alan J. | Method and apparatus for performing a lateral flow assay |
WO2003098278A2 (fr) * | 2002-05-17 | 2003-11-27 | Applera Corporation | Appareil et procede pour differencier par longueur d'onde d'excitation des signaux de fluorescence multiples |
WO2004003527A1 (fr) * | 2002-06-27 | 2004-01-08 | Unipath Limited | Lecteur de test |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006003380B4 (de) * | 2005-01-26 | 2013-02-07 | Alverix, Inc. | Untersuchungsteststreifen mit mehreren Markierungen und Lesen derselben |
WO2008019695A3 (fr) * | 2006-08-16 | 2008-07-17 | Thor Publishing | système d'essai interactif permettant d'analyser des échantillons biologiques |
US8924226B2 (en) | 2006-08-16 | 2014-12-30 | Sime Diagnostics Aps | Interactive testing system for analysing biological samples |
WO2008019695A2 (fr) * | 2006-08-16 | 2008-02-21 | Thor Publishing | système d'essai interactif permettant d'analyser des échantillons biologiques |
EP3260846A3 (fr) * | 2010-07-20 | 2018-01-17 | Roche Diabetes Care GmbH | Dispositif de contrôle d'un analyte dans un liquide corporel |
WO2012010454A1 (fr) * | 2010-07-20 | 2012-01-26 | F. Hoffmann-La Roche Ag | Dispositif de détection d'un analyte dans un liquide corporel |
CN102985810A (zh) * | 2010-07-20 | 2013-03-20 | 霍夫曼-拉罗奇有限公司 | 用于鉴定体液中的分析物的设备 |
US10724943B2 (en) | 2010-07-20 | 2020-07-28 | Roche Diabetes Care, Inc. | Device for detecting an analyte in a bodily fluid |
US9228935B2 (en) | 2010-07-20 | 2016-01-05 | Roche Diabetes Care, Inc. | Device for detecting an analyte in a bodily fluid |
CN102985810B (zh) * | 2010-07-20 | 2016-04-27 | 霍夫曼-拉罗奇有限公司 | 用于鉴定体液中的分析物的设备 |
US10031067B2 (en) | 2010-07-20 | 2018-07-24 | Roche Diabetes Care, Inc. | Device and method for detecting an analyte in a bodily fluid using a test element |
US9851366B2 (en) | 2011-01-18 | 2017-12-26 | Symbolics, Llc | Lateral flow assays using two dimensional features |
US9874576B2 (en) | 2011-01-18 | 2018-01-23 | Symbolics, Llc | Lateral flow assays using two dimensional features |
US11016090B2 (en) | 2011-01-18 | 2021-05-25 | Symbolics, Llc | Lateral flow assays using two dimensional features |
US9874556B2 (en) | 2012-07-18 | 2018-01-23 | Symbolics, Llc | Lateral flow assays using two dimensional features |
US10180400B2 (en) | 2013-08-20 | 2019-01-15 | Optricon Entwicklungsgesellschaft Fur Optische Technologien Mbh | Device for digital reading of quick tests |
WO2015024553A1 (fr) * | 2013-08-20 | 2015-02-26 | opTricon Entwicklungsgesellschaft für Optische Technologien mbH | Dispositif de lecture numérique pour des tests de diagnostic rapide |
DE102014012434B4 (de) | 2013-08-20 | 2023-01-05 | Chembio Diagnostics Gmbh | Vorrichtung zur digitalen Auswertung eines Teststreifens |
GB2542802A (en) * | 2015-09-30 | 2017-04-05 | Cambridge Display Tech Ltd | Organic-based fluorescence sensor with low background signal |
WO2020049066A1 (fr) * | 2018-09-04 | 2020-03-12 | Ams Ag | Lecteur de biomarqueurs |
CN112654858A (zh) * | 2018-09-04 | 2021-04-13 | ams有限公司 | 生物标志物读取器 |
EP3772646B1 (fr) * | 2019-08-06 | 2024-04-24 | ams-OSRAM AG | Bande de test, dispositif de surveillance et procédé de fabrication d'une bande de test |
Also Published As
Publication number | Publication date |
---|---|
US20050221504A1 (en) | 2005-10-06 |
CA2496986A1 (fr) | 2005-10-01 |
DE602004011471D1 (de) | 2008-03-13 |
EP1582598B1 (fr) | 2008-01-23 |
US20050221505A1 (en) | 2005-10-06 |
CN1677105A (zh) | 2005-10-05 |
DE602004011471T2 (de) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1582598B1 (fr) | Système optoélectronique rapid pour tests de diagnostic rapide | |
EP1634062B1 (fr) | Tete de lecture pour appareil d'inspection optique | |
KR100251999B1 (ko) | 시험 스트립용 판독 장치 | |
US5701181A (en) | Fiber optic diffuse light reflectance sensor utilized in the detection of occult blood | |
CN104081210B (zh) | 具有气动式样本致动的光学测定装置 | |
US7339673B2 (en) | Miniature optical readhead for optical diagnostic device | |
US20110223673A1 (en) | Polarized Optics for Optical Diagnostic Device | |
US20050186682A1 (en) | Apparatus and method for process monitoring | |
US20210349023A1 (en) | Biomarker reader | |
CA3112973A1 (fr) | Dispositifs et procede de mesure d'une concentration d'analyte dans un echantillon de fluide corporel | |
EP2990779B1 (fr) | Dispositif de détection d'objet analysé dans un échantillon et procédé pour celui-ci | |
DE102005045105A1 (de) | Diagnosetest unter Verwendung einer torgesteuerten Messung der Fluoreszenz von Quantenpunkten | |
JP2004138619A (ja) | 試験線条体の過少配量の検出および補償方法 | |
US20230003722A1 (en) | Methods and compositions for lateral flow analyte assays | |
WO2022236120A9 (fr) | Diagnostic de point d'intervention en temps réel et méthode d'utilisation associée | |
CN210166298U (zh) | 一种可用于干化学分析和免疫学分析的信息采集装置 | |
RU2797009C2 (ru) | Устройства и способ измерения концентрации аналита в образце физиологической жидкости | |
RU2797009C9 (ru) | Устройства и способ измерения концентрации аналита в образце физиологической жидкости | |
JP7385649B2 (ja) | 体液サンプル中の分析物濃度を測定するための装置および方法 | |
US20190195844A1 (en) | Analysis Apparatus with Spectrometer | |
CN116829925A (zh) | 光学模块 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR LV MK YU |
|
17P | Request for examination filed |
Effective date: 20060125 |
|
AKX | Designation fees paid |
Designated state(s): CH DE FR GB LI |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD |
|
17Q | First examination report despatched |
Effective date: 20070327 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): CH DE FR GB LI |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 602004011471 Country of ref document: DE Date of ref document: 20080313 Kind code of ref document: P |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: ALVERIX, INC. |
|
26N | No opposition filed |
Effective date: 20081024 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: ALVERIX, INC. Free format text: AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD#NO. 1 YISHUN AVENUE 7#SINGAPORE 768923 (SG) -TRANSFER TO- ALVERIX, INC.#2590 NORTH FIRST STREET, SUITE 100#SAN JOSE, CA 95131 (US) Ref country code: CH Ref legal event code: NV Representative=s name: BOVARD AG PATENTANWAELTE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20090226 AND 20090304 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: ALVERIX, INC. Free format text: ALVERIX, INC.#2590 NORTH FIRST STREET, SUITE 100#SAN JOSE, CA 95131 (US) -TRANSFER TO- ALVERIX, INC.#2590 NORTH FIRST STREET, SUITE 100#SAN JOSE, CA 95131 (US) |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231121 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20231122 Year of fee payment: 20 Ref country code: DE Payment date: 20231121 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240101 Year of fee payment: 20 |